Genedrive (GB:GDR) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Genedrive PLC has reported significant advances in its pharmacogenetic testing products, with revenues reaching £0.5 million and a successful £6 million equity fundraise. The company received positive endorsements from NICE and the FDA, and its products are now being used in the UK and overseas. With a strong cash position and ongoing market expansion efforts, Genedrive is poised for growth in 2025.
For further insights into GB:GDR stock, check out TipRanks’ Stock Analysis page.
